Ceylon cinnamon
The 'true' cinnamon (Cinnamomum verum), valued primarily as a safer alternative to cassia for people who use cinnamon supplements daily. Coumarin content is ~100× lower than cassia, eliminating the chronic liver-toxicity concern. Glycemic effects exist (modest fasting glucose reduction in meta-analyses) but most clinical trials used cassia, not Ceylon, and HbA1c benefit is unproven.
Quick decision guide
May help most
People who already use 1+ g cinnamon daily and want to avoid coumarin exposure — choose Ceylon instead of cassia. Also reasonable as a flavor / functional spice with very low toxicity.
Common dosing range
Culinary: ½–1 tsp daily (1–3 g). Supplements: 500 mg–2 g/day powder; 100–500 mg standardized extract.
When to expect effects
Weeks (for any glycemic effect); none expected for general use.
Watch out for
Don't expect dramatic blood-sugar effects. If using cassia at high daily doses, switch to Ceylon to avoid coumarin/liver risk.
Evidence snapshot
What is it
Ceylon cinnamon, also called true cinnamon or Sri Lankan cinnamon, is derived from the dried inner bark of Cinnamomum verum (synonym Cinnamomum zeylanicum ), a small evergreen tree native to Sri Lanka and the western Indian Ghats. It differs importantly from cassia cinnamon (Cinnamomum cassia, C. burmannii, C. loureiroi), which dominates commercial cinnamon in North America and much of Europe; Ceylon cinnamon has a finer flavour, lower content of coumarin (a coumarinogenic hepatotoxin) - typically below 0.04% versus 0.5-12% in cassia varieties - and a softer, easily crumbled bark texture. Active constituents include cinnamaldehyde, eugenol, cinnamic acid, and proanthocyanidins, which underlie its glucose-modulating, antimicrobial, and antioxidant activity.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Lower coumarin exposure vs cassia cinnamon Good Evidence | ~100× less coumarin per gram than cassia; effectively eliminates chronic liver-toxicity risk from coumarin | Daily/heavy cinnamon users (smoothies, oatmeal, capsules), children regularly eating cinnamon-heavy foods, anyone on hepatotoxic medications | Immediate switching benefit |
Glycemic control in type 2 diabetes Limited Evidence | FPG −24.59 mg/dL across trials; HbA1c −0.16% (NOT statistically significant). Most trials used cassia, not Ceylon. | Type 2 diabetes patients using cinnamon as a low-risk adjunct alongside standard care | Weeks (trials ran 4–18 weeks) |
Lipid profile (LDL, triglycerides) Limited Evidence | LDL −9.42 mg/dL, TG −29.59 mg/dL in meta-analysis; high heterogeneity | Type 2 diabetes patients with mild dyslipidemia using cinnamon as low-risk adjunct | Weeks |
Antimicrobial / oral health Mixed Evidence | In-vitro antimicrobial activity; clinical-endpoint trials largely absent | Adjunct use in oral-hygiene products marketed for fresh breath | Not established |
Lower coumarin exposure vs cassia cinnamon
- Effect
- ~100× less coumarin per gram than cassia; effectively eliminates chronic liver-toxicity risk from coumarin
- Best fit
- Daily/heavy cinnamon users (smoothies, oatmeal, capsules), children regularly eating cinnamon-heavy foods, anyone on hepatotoxic medications
- Time
- Immediate switching benefit
Glycemic control in type 2 diabetes
- Effect
- FPG −24.59 mg/dL across trials; HbA1c −0.16% (NOT statistically significant). Most trials used cassia, not Ceylon.
- Best fit
- Type 2 diabetes patients using cinnamon as a low-risk adjunct alongside standard care
- Time
- Weeks (trials ran 4–18 weeks)
Lipid profile (LDL, triglycerides)
- Effect
- LDL −9.42 mg/dL, TG −29.59 mg/dL in meta-analysis; high heterogeneity
- Best fit
- Type 2 diabetes patients with mild dyslipidemia using cinnamon as low-risk adjunct
- Time
- Weeks
Antimicrobial / oral health
- Effect
- In-vitro antimicrobial activity; clinical-endpoint trials largely absent
- Best fit
- Adjunct use in oral-hygiene products marketed for fresh breath
- Time
- Not established
Evidence for 4 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Lower coumarin exposure vs cassia cinnamon
Ceylon cinnamon (Cinnamomum verum) contains trace coumarin (<10 mg/kg), while cassia varieties (C. cassia, C. burmannii, C. loureiroi) can contain 3,000–5,000 mg/kg. The EFSA tolerable daily intake for coumarin is 0.1 mg/kg body weight — easily exceeded by daily 1+ tsp cassia consumption, especially in children. Coumarin is hepatotoxic in chronic high exposure (acute hepatitis cases documented at 1–2 g/day cassia). Switching to Ceylon essentially eliminates the coumarin concern. This isn't a 'benefit' in the traditional sense — it's avoidance of a substitution risk.
Bottom line: If you use cinnamon daily, Ceylon is the clearly safer choice. For occasional culinary use either is fine.
Glycemic control in type 2 diabetes
Biomarker supportThe Allen 2013 meta-analysis pooled 10 RCTs (543 patients) using cinnamon at 120 mg to 6 g/day for 4–18 weeks. Significant reductions appeared in fasting plasma glucose (−24.59 mg/dL), total cholesterol, LDL, and triglycerides; HDL rose modestly. But HbA1c — the gold-standard glycemic outcome — was not significantly affected (−0.16%; 95% CI −0.39 to +0.02). Most included trials used cassia varieties, not Ceylon specifically. High between-study heterogeneity (I² 66–95%) limits confidence in pooled estimates.
Bottom line: Modest fasting glucose effect; HbA1c benefit unproven. Don't replace diabetes meds with cinnamon.
Evidence is mixed
Fasting glucose drops modestly but HbA1c — the metric clinicians use to assess diabetes control — is unchanged. Heterogeneity is high. NCCIH summarizes the evidence as not clearly supporting any health condition.
Lipid profile (LDL, triglycerides)
Biomarker supportThe Allen 2013 meta-analysis reported reductions in total cholesterol (−15.60 mg/dL), LDL (−9.42 mg/dL), and triglycerides (−29.59 mg/dL) alongside the glycemic findings. Mechanism plausible (cinnamon inhibits hepatic HMG-CoA reductase, the statin target, in lab studies). Same caveats: high heterogeneity, most trials used cassia, single trials with conflicting results, no hard cardiovascular endpoint data.
Bottom line: Mild lipid effects in pooled data, but no hard outcome evidence and most trials used cassia.
Antimicrobial / oral health
Mechanism onlyCinnamaldehyde and related compounds show in-vitro antibacterial and antifungal activity (against Candida, S. mutans, etc.). Some small trials of cinnamon mouthwashes report reduced oral bacterial counts. No high-quality clinical evidence for any specific oral or systemic infection indication.
Bottom line: Plausible mechanism, no clinical-outcome evidence worth acting on.
How to take it
What to track
Bottom line: Use Ceylon (not cassia) for daily 1+ g use. Don't substitute for diabetes medications. Reassess after 8–12 weeks.
4 commercial forms
Compare the main delivery options and what they’re best suited for.
Ceylon cinnamon powder
Most versatileThe standard culinary form. Sprinkle on oatmeal, smoothies, coffee. Pale beige-tan color. ~½ tsp delivers ~1 g. Choose for daily/heavy use.
Whole-spice form; antioxidants and cinnamaldehyde intact.
Ceylon cinnamon sticks (quills)
For infusionsThin, layered cinnamon bark. Use for tea, chai, mulled drinks. Lower per-serving dose than powder. Identifies authenticity visually (Ceylon has multiple thin layers; cassia is one thick curl).
Mainly aromatic compounds extracted into liquid; lower polyphenol delivery than powder.
Standardized water-soluble cinnamon extract
ConcentratedOften labeled 'Cinnulin PF' or similar (originally from cassia, but Ceylon-based versions exist). Concentrates the water-soluble polyphenol fraction (Type A polymers, MHCP) thought to drive insulin-mimetic effects. 100–500 mg/day in trials.
Removes the lipid-soluble fraction (including most coumarin if cassia-derived); concentrates active polyphenols.
Cinnamon essential oil
Topical onlyHighly concentrated cinnamaldehyde — irritating to mucous membranes and skin. Not for internal use. Some flavor and aromatherapy applications.
Not appropriate for oral supplementation.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Hepatotoxicity from coumarin — a chronic concern with CASSIA (not Ceylon). Acute hepatitis case reports tied to 1–2 g/day cassia for months. Ceylon's trace coumarin essentially eliminates this risk.
Cinnamon-induced hepatitis case reports specifically in patients on statins or other hepatotoxic medications (mechanism beyond coumarin).
Aspiration risk and lung damage from inhaling dry cinnamon powder (the 'cinnamon challenge') — emergency-room cases documented.
Who should avoid it
- People with active liver disease should limit any high-dose cinnamon (Ceylon or cassia).
- Pregnant women considering large daily supplemental doses — NCCIH flags this as unsafe for both Ceylon and cassia.
- People with cinnamaldehyde allergy (contact dermatitis, oral irritation).
Pregnancy & breastfeeding
Culinary amounts in food are considered safe. Large supplemental doses are NOT considered safe in pregnancy per NCCIH — both Ceylon and cassia. Talk to your obstetrician before any supplement use.
Bottom line: Ceylon is the safer choice for daily use. The coumarin liver risk is a cassia problem. Aspiration of dry cinnamon powder is a real ER risk.
Interactions
Case reports of cinnamon-associated hepatitis in patients on statins. MSKCC notes both share hepatic metabolism; combined hepatotoxicity is possible.
Mostly a cassia coumarin concern (coumarin derivatives have anticoagulant activity). Ceylon's trace coumarin makes this much less relevant, but monitor INR if combining high-dose cinnamon with warfarin.
Cinnamon inhibits CYP2C9 in lab studies and can increase pioglitazone bioavailability. Clinical significance unclear.
Cinnamon may modestly lower fasting glucose; theoretical additive hypoglycemia. Monitor blood sugar if combining.
Avoid stacking with other hepatotoxic agents, especially at high cinnamon doses.
Protocols featuring Ceylon cinnamon
Evidence-backed routines where Ceylon cinnamon plays a role.
Blood Sugar / Insulin Resistance
metabolic
Insulin resistance is upstream of nearly every chronic disease that kills modern adults: type 2 diabetes, cardiovascular disease, fatty liver, cognitive decline, certain cancers. The good news is it''s one of the most reversible metabolic states — with lifestyle change being the strongest lever (Diabetes Prevention Program: 58% reduction in progression to diabetes vs. 31% for metformin). The supplement category has genuine evidence: berberine produces effects comparable to metformin for HbA1c and fasting glucose; chromium and alpha-lipoic acid improve insulin sensitivity; cinnamon (Ceylon variety) modestly reduces post-meal glucose spikes; magnesium corrects a commonly low cofactor in insulin signaling. This stack is for adults with elevated fasting glucose, elevated HbA1c, elevated fasting insulin, or known insulin resistance — including those with PCOS, prediabetes, or metabolic syndrome. It complements lifestyle change rather than substituting for it. If your HbA1c is over 6.5% or your fasting glucose is over 126 mg/dL, you have type 2 diabetes — that''s a medical condition that warrants proper management, not solo supplementation.
GLP-1 Support (Natural)
metabolic
GLP-1 (glucagon-like peptide-1) is the hormone behind the medications driving the 2025-2026 weight-loss revolution. Some natural compounds modestly support endogenous GLP-1 release, glucose handling, and satiety — they are not substitutes for prescription GLP-1 agonists, but they can be a starting point for metabolic health support or a complement to lifestyle change. Berberine has the strongest evidence and is sometimes called "nature's metformin" (not Ozempic — the comparison is exaggerated). Soluble fiber works through gastric emptying and direct GLP-1 stimulation. Cinnamon and apple cider vinegar have smaller, supporting roles for postprandial glucose.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Ceylon cinnamon, ground | 1 tsp (~2.6 g) | — |
| Ceylon cinnamon stick (quill) | 1 stick (~1.5 g) | — |
| Cinnamon-spiced oatmeal | 1 bowl (~1–2 g cinnamon) | — |
| Chai tea (Ceylon-based) | 1 cup (~0.5–1 g infused) | — |
Ceylon cinnamon, ground
- Amount
- 1 tsp (~2.6 g)
- %DV
- —
Ceylon cinnamon stick (quill)
- Amount
- 1 stick (~1.5 g)
- %DV
- —
Cinnamon-spiced oatmeal
- Amount
- 1 bowl (~1–2 g cinnamon)
- %DV
- —
Chai tea (Ceylon-based)
- Amount
- 1 cup (~0.5–1 g infused)
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
References by claim
Antimicrobial / oral health
Memorial Sloan Kettering — About Herbs — Cinnamon (2024) link
Glycemic control in type 2 diabetes
Lower coumarin exposure vs cassia cinnamon
Track Ceylon cinnamon with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.